Published in Lab Business Week, November 26th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Research and Markets.
Report 1: Research and Markets has announced the addition of the new report from Datamonitor, "Stakeholder Insight: Rheumatoid Arthritis - Biologics Battle Up the Treatment Algorithm," to their offering.
Rheumatoid arthritis (RA) is a debilitating and life-long disease that is estimated to affect approximately 5 million people in the seven major markets. The launch of anti-TNF products over six years ago and more recent novel target biologic therapies...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.